SCHEMBL92576

SCHEMBL92576

CC1(CN)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19242261 1.00 USP2 (0.36)
SCHEMBL19069681 1.00 USP2 (0.36)
SCHEMBL12361078 1.00 USP2 (0.36)
SCHEMBL5118439 1.00 USP2 (0.36)
SCHEMBL18610573 1.00 USP2 (0.36)
SCHEMBL13849408 1.00 USP2 (0.36)
SCHEMBL12361074 1.00 USP2 (0.36)
SCHEMBL18879736 1.00 USP2 (0.36)
Hydrochloric Acid SCHEMBL25345453 0.97 USP2 (0.34)
SCHEMBL3249011 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7193077-B2 Exocyclic amine triaryl methyl protecting groups in two-step polynucleotide synthesis AGILENT TECHNOLOGIES, INC. (US) 2007-03-20 US claimed
US-5602244-A DINUCLEOSIDE PRECURSORS IN OLIGONUCLEOTIDE SYNTHESIS; USEFUL AS ANTISENSE INHIBITORS OF TRANSLATION COMPETITIVE TECHNOLOGIES, INC. (US) 1997-02-11 US claimed
EP-0144386-B1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS, INC. (US) 1989-09-06 EP claimed
EP-0144386-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES. BECKMAN INSTRUMENTS INC (US) 1985-06-19 EP claimed
WO-1984004749-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS INC (US) 1984-12-06 WO claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 EP disclosed
US-12435051-B2 Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof VIVOZON, INC. (KR) 2025-10-07 US disclosed
CN-112533902-B Composition comprising a nitroxide inhibitor, a quinone methide blocker and an amine stabilizer to inhibit polymerization of monomers 埃科莱布美国股份有限公司 2025-03-14 CN disclosed
CN-116234552-B Dual modulators of mGluR5 and 5-HT2A receptors and uses thereof (株)倍宝尊 2025-02-25 CN disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 EP disclosed
US-20240360092-A1 DUAL MODULATOR OF MGLUR5 AND 5-HT2A RECEPTOR, AND USE THEREOF VIVOZON INC. (KR) 2024-10-31 US disclosed
EP-0225807-A2 Solution phase nucleic acid sandwich assay and polynucleotide probes useful therein CHIRON CORPORATION (US) 1987-06-16 EP disclosed
US-4668777-A POLYNUCLEOTIDE INTERMEDIATES UNIVERSITY PATENTS, INC. (US) 1987-05-26 US disclosed
EP-0196101-A2 Purification of synthetic oligomers CHIRON CORPORATION (US) 1986-10-01 EP disclosed
EP-0144386-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES. BECKMAN INSTRUMENTS INC (US) 1985-06-19 EP disclosed
WO-1984004749-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS INC (US) 1984-12-06 WO disclosed
US-4415732-A STORAGE-STABLE NUCLEOSIDES; POLYNUCLEOTIDE SYNTHESIS UNIVERSITY PATENTS, INC. (US) 1983-11-15 US disclosed
EP-0061746-A1 Phosphoramidite compounds and their use in producing oligonucleotides UNIVERSITY PATENTS, INC. (US) 1982-10-06 EP disclosed
US-4024175-A Cyclic amino acids WARNER-LAMBERT COMPANY (US) 1977-05-17 US disclosed